Douglas J. Manion - Mar 9, 2023 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Mar 9, 2023
Transactions value $
$50,278
Form type
4
Date filed
3/9/2023, 04:56 PM
Previous filing
Feb 3, 2023
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Purchase $50.3K +6.5K $7.74 6.5K Mar 9, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.